Contract kickoff conference call for CRO support for ncats medicinal chemistry for lead optimization.
Ended Awarded Last action
- Contract number
- 75N95019F00088
- Awardee
-
Lovelace Biomedical Research Institute UEI MBT9RXJJ7428
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,000
Award facts
- Opportunity
-
- N01TR192007 Solicitation number
- CRO Support for NCATS Medicinal Chemistry for Lead Optimization Award Notice · Posted Nov 6, 2018
- Contract value 100% obligated
- $1,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 9 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Albuquerque, NM 87108, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$4,000 | |
| Other Administrative Action | $0 | |
| Original award | $5,000 |
About this award
This delivery order against the CRO Support for NCATS Medicinal Chemistry for Lead Optimization master IDIQ contract with the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences provides $1,000 for a kickoff conference call in support of medicinal chemistry for lead optimization. The prime contractor is Lovelace Biomedical Research Institute, located in Albuquerque, New Mexico. No set-aside designation was applied to this award. The National Center for Advancing Translational Sciences drives innovation by conducting and funding research to advance new diagnostics and therapies.
Quick answers
Who was awarded contract 75N95019F00088?
75N95019F00088 was awarded to Lovelace Biomedical Research Institute by National Institute on Drug Abuse (National Institutes of Health) on September 23, 2019.
How much is contract 75N95019F00088 worth?
The government has obligated $1,000 on 75N95019F00088.
Which agency awarded contract 75N95019F00088?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95019F00088, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Is contract 75N95019F00088 an order under another contract?
Yes. 75N95019F00088 is a delivery order under 75N95019D00030, an indefinite delivery contract, on CRO Support for NCATS Medicinal Chemistry for Lead Optimization.
Was contract 75N95019F00088 competed?
The extent of competition for 75N95019F00088 was full and open competition. The government received 9 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award